You are here: Industry Insights > Top-Line

News List

Janssen Reports Top-Line Phase 3 Results for TREMFYA® americanpharmaceuticalreview
June 20, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson announced top-line results from the Phase 3 DISCOVER 1 and 2 studies, which evaluated the efficacy and safety of guselkumab compared to placebo in adult patients with active moderate to severe psor
SPARC announces top-line results of Pivotal Bioequivalence Study expressbpd
November 26, 2018
Sun Pharma Advanced Research Company (SPARC) recently announced top-line results of the pivotal BE study for Paclitaxel Injection Concentrate for Suspension (PICS).
SPARC announces top-line results of Pivotal Bioequivalence Study expressbpd
November 26, 2018
Sun Pharma Advanced Research Company (SPARC) recently announced top-line results of the pivotal BE study for Paclitaxel Injection Concentrate for Suspension (PICS).
Braeburn Announces Positive Top-line Phase 3 Results for CAM2038 americanpharmaceuticalreview
September 20, 2018
Braeburn announces positive top-line results for a Phase 3 study of CAM2038 for the treatment of moderate-to-severe Chronic Low Back Pain (CLBP) in patients previously on long-term daily opioid therapy. CAM2038 is an investigational buprenorphine weekly a
Egalet Announces Positive Top-Line Results from Egalet-002 Study americanpharmaceuticacreview
November 20, 2017
Egalet announced positive top-line results from a phase 3 study evaluating the safety of Egalet-002, an abuse-deterrent, extended-release oxycodone developed using an application of the Guardian Technology.